Related Experiment Video

Updated: Jun 1, 2026

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
04:59

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases

Published on: June 20, 2025

Vascular disease and stem cell therapies

Gabriel P Lasala1, Jose J Minguell

  • 1TCA Cellular Therapy, Covington, LA 70433, USA. drlasala@tcacellulartherapy.com

British Medical Bulletin
|May 19, 2011
PubMed

Insights

Stem cells show promise for treating limb ischemia (LI), a complication of peripheral vascular disease. Bone marrow-derived mesenchymal stem cells may be superior to mononuclear cells, with combinations potentially offering enhanced benefits for LI patients.

Area of Science:

  • Regenerative Medicine
  • Vascular Biology
  • Stem Cell Therapy

Background:

  • Peripheral vascular disease is a primary cause of limb ischemia (LI), characterized by pain, ulcers, or gangrene.
  • Atherosclerosis-driven peripheral arterial disease underlies most LI cases.
  • Stem cell therapy has emerged as a potential treatment strategy for LI over the past decade.

Purpose of the Study:

  • To review the current evidence and ongoing clinical trials for stem cell therapy in treating limb ischemia.
  • To identify areas of consensus and controversy in the application of stem cells for LI.
  • To highlight promising research directions for future stem cell-based therapies for LI.

Main Methods:

  • Systematic review of published medical literature.
  • Analysis of clinical trials registered on clinicaltrials.gov.
  • Inclusion of cellular therapy experience from TCA.

Main Results:

  • General agreement exists on the utility of stem cells for treating limb ischemia.
  • Key areas of controversy include cell type, dosage, administration route, and efficacy evaluation methods.

Conclusions:

  • Bone marrow-derived mesenchymal stem cells show comparable or superior efficacy to mononuclear cells.
  • Combinations of cell types, including adult or induced pluripotent stem cells, may offer improved outcomes.
  • Future research should explore combinations of stem cells with growth factors or extracellular matrix molecules for enhanced therapeutic effects in LI.
Abstract

More Related Videos

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles09:01

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...